DB05243 | XL019 | investigational | unknown | | Details |
DB04716 | 2-tert-butyl-9-fluoro-1,6-dihydrobenzo[h]imidazo[4,5-f]isoquinolin-7-one | experimental | unknown | | Details |
DB07161 | 5-phenyl-1H-indazol-3-amine | experimental | unknown | | Details |
DB07162 | 4-(3-amino-1H-indazol-5-yl)-N-tert-butylbenzenesulfonamide | experimental | unknown | | Details |
DB08067 | 4-[(2-{4-[(CYCLOPROPYLCARBAMOYL)AMINO]-1H-PYRAZOL-3-YL}-1H-BENZIMIDAZOL-6-YL)METHYL]MORPHOLIN-4-IUM | experimental | unknown | | Details |
DB08877 | Ruxolitinib | approved | yes | inhibitor | Details |
DB08895 | Tofacitinib | approved, investigational | yes | antagonistinhibitor | Details |
DB11817 | Baricitinib | approved, investigational | yes | inhibitor | Details |
DB12010 | Fostamatinib | approved, investigational | unknown | inhibitor | Details |
DB12500 | Fedratinib | approved, investigational | yes | inhibitor | Details |
DB11986 | Entrectinib | approved, investigational | unknown | inhibitor | Details |
DB15035 | Zanubrutinib | approved, investigational | unknown | inhibitor | Details |
DB15822 | Pralsetinib | approved, investigational | unknown | inhibitor | Details |
DB14973 | Abrocitinib | approved, investigational | unknown | inhibitor | Details |
DB11697 | Pacritinib | approved, investigational | yes | inhibitor | Details |